HYDANTIN

Main information

  • Trade name:
  • HYDANTIN 100 mg tablet
  • Dosage:
  • 100 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • HYDANTIN 100 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Phenytoin
  • Product summary:
  • Suitability for use in older adult patients Phenytoinum Avoid using in older persons. Sedative. Start therapy under specialist supervision. Narrow therapeutic range. Concentration increase difficult to predict. Monitor the drug concentration. Low albumin level in serum increases the response. Significant adverse effects include tiredness, dizziness, gingival hyperplasia, osteomalacia, hepatotoxicity and changes in blood count. Take several interactions into account.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 3112
  • Authorization date:
  • 08-10-2007
  • Last update:
  • 21-02-2018